Search

everythinglearnresearchcommunity

for

Search:↓

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Hair follicles play a crucial role in regulating skin barrier function.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Secukinumab for psoriasis may cause hair loss.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Certain gene variations are linked to alopecia areata.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Finasteride reduces some inflammation in BPH but not all.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.